Atlas Trials

Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)

Clinical trial NCT03859544 · UNKNOWN

Trial details

NCT number
NCT03859544
Sponsor
Hospices Civils de Lyon
Status
UNKNOWN
Study type
OBSERVATIONAL
Central Nervous System Lymphoma
Start date
2016-01-01
Primary completion
2020-01-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.